Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-002253
Filing Date
2017-05-15
Accepted
2017-05-15 12:13:46
Documents
32
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gluc_10q.htm 10-Q 187843
2 CERTIFICATION gluc_ex311.htm EX-31.1 7472
3 CERTIFICATION gluc_ex321.htm EX-32.1 3436
  Complete submission text file 0001477932-17-002253.txt   1295072

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT gluc-20170331.xml EX-101.INS 152579
5 XBRL TAXONOMY EXTENSION SCHEMA gluc-20170331.xsd EX-101.SCH 31210
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gluc-20170331_cal.xml EX-101.CAL 26375
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gluc-20170331_def.xml EX-101.DEF 29605
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gluc-20170331_lab.xml EX-101.LAB 146366
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gluc-20170331_pre.xml EX-101.PRE 92224
Mailing Address 609 SW 8TH STREET 6TH FLOOR BENTONVILLE AR 72712
Business Address 609 SW 8TH STREET 6TH FLOOR BENTONVILLE AR 72712 (888) 987-6315
Glucose Health, Inc. (Filer) CIK: 0001420108 (see all company filings)

EIN.: 901117742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55439 | Film No.: 17842566
SIC: 2833 Medicinal Chemicals & Botanical Products